Tirzepatide
60mg
⚠️ Not for human consumption. Research purposes only.
$199.99
Description
Tirzepatide is a dual GIP and GLP-1 receptor agonist that has shown remarkable results for both weight loss and blood sugar control. It is one of the most effective treatments currently available for obesity and type 2 diabetes.
Key Areas of Study
- Remarkable weight loss
- improved blood sugar control
- enhanced insulin sensitivity
Mechanisms Being Evaluated
Activates both the GIP and GLP-1 receptors, leading to significant appetite reduction, increased insulin sensitivity, and improved glucose metabolism.
Commonly Researched Uses
Significant weight management, metabolic health improvement for individuals with obesity and/or type 2 diabetes
Recent Studies and Trials
The following peer-reviewed studies and clinical trials have investigated the properties and applications of this peptide:
Tirzepatide for Type 2 Diabetes: SURPASS Trials
Published: 2021
SURMOUNT-1: Weight Reduction Study
Published: 2022
Cardiovascular Outcomes with Tirzepatide
Published: 2023
Note: These studies are provided for informational and research purposes only. This product is not intended for human consumption.